Pretomanid: XDR-TB may soon become easily treatable
Though the total number of people with XDR-TB and treatment intolerant or non-responsive MDR-TB who will require the new anti-TB drug Pretomanid may not be high, these are people who…
Category: XDR-TB
Explainer: What makes the new drug-resistant TB medicine Pretomanid promising
When used in combination with bedaquiline and linezolid, the newly approved pretomanid drug for MDR-TB and XDR-TB had an overall treatment success rate of about 90%. Besides better effectiveness, the…
IISc researchers’ quest to make a common antibiotic more effective against TB
Bacteria develop resistance against a drug only when they are exposed to it or when the drug is misused. But now, a team of researchers from India has found whether…
Breaking the drug-resistant TB transmission cycle important
Nearly two months after the Health Ministry set a highly ambitious target of working towards elimination of tuberculosis by 2025, a study published in The Lancet Infectious Diseases indicates that India’s TB…
Working towards personalised TB treatment
Three major global research centres in India will receive funding coming out of collaboration between the UK Medical Research Council (MRC) and the Department for Biotechnology (DBT), India. The Department…
Editorial: An ominous situation
That the medicine chest is bereft of effective new drugs to fight the extremely drug-resistant tuberculosis (XDR-TB) strain has once again become frighteningly clear. According to a study published recently…
‘Long-term outcomes in South African patients with XDR-TB poor’
Long-term outcomes in South African patients who have extremely-drug resistant tuberculosis (XDR-TB) are “poor” immaterial of HIV status, notes a paper published on January 17 in The Lancet . Despite…
TB: ‘There is a clearly higher risk of mortality in children of 0-4 years’
With 8.6 million people across the world developing tuberculosis in 2012 and nearly 1.3 million succumbing to the disease, and with the number of people with multi-drug resistant TB (MDR-TB)…
Science Chronicle 